Tricia Borga Suvari Global Blood Therapeutics, Inc. (GBT) insider trading activity

Tricia Borga Suvari is Chief Legal Officer of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2022, when has been sold 43,077 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

TRICIA BORGA SUVARI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 05 2022	SELL Sale (or disposition) back to the issuer	-	43,077 Reduced 100.0%	0 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$128,190 $68.15 p/Share	1,881 Reduced 4.18%	43,077 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	4,971 Added 9.96%	44,958 Common Stock
Aug 31 2022	BUY Grant, award, or other acquisition	$9,767 $25.37 p/Share	385 Added 0.95%	39,987 Common Stock
Aug 01 2022	SELL Payment of exercise price or tax liability	$68,882 $32.4 p/Share	2,126 Reduced 5.09%	39,602 Common Stock
Aug 01 2022	BUY Exercise of conversion of derivative security	-	6,145 Added 12.84%	41,728 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$28,556 $29.87 p/Share	956 Reduced 2.61%	35,653 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	2,763 Added 7.02%	36,609 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	$11,493 $25.37 p/Share	453 Added 1.32%	33,846 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$101,775 $29.33 p/Share	3,470 Reduced 9.41%	33,393 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	-	9,395 Added 20.31%	36,863 Common Stock
Sep 01 2021	SELL Payment of exercise price or tax liability	$31,253 $29.85 p/Share	1,047 Reduced 3.67%	27,468 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	-	2,762 Added 8.83%	28,515 Common Stock
Aug 31 2021	BUY Grant, award, or other acquisition	$1,049 $24.39 p/Share	43 Added 0.17%	25,753 Common Stock
Aug 01 2021	SELL Payment of exercise price or tax liability	$88,822 $27.33 p/Share	3,250 Reduced 11.22%	25,710 Common Stock
Aug 01 2021	BUY Exercise of conversion of derivative security	-	9,395 Added 24.49%	28,960 Common Stock
Feb 28 2021	BUY Grant, award, or other acquisition	$12,384 $36.21 p/Share	342 Added 1.72%	19,565 Common Stock
Feb 01 2021	SELL Payment of exercise price or tax liability	$168,217 $49.49 p/Share	3,399 Reduced 15.03%	19,223 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	-	9,395 Added 29.34%	22,622 Common Stock

TBS

Tricia Borga Suvari

Chief Legal Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Value

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Global Blood Therapeutics, Inc.

Track Activities on GBT

Account